HCSGD entry for BCL6
1. General information
Official gene symbol | BCL6 |
---|---|
Entrez ID | 604 |
Gene full name | B-cell CLL/lymphoma 6 |
Other gene symbols | BCL5 BCL6A LAZ3 ZBTB27 ZNF51 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000060 | Protein import into nucleus, translocation | IGI | biological_process |
GO:0000122 | Negative regulation of transcription from RNA polymerase II promoter | IDA IEA | biological_process |
GO:0000902 | Cell morphogenesis | IEA | biological_process |
GO:0001953 | Negative regulation of cell-matrix adhesion | IEA | biological_process |
GO:0002467 | Germinal center formation | IEA | biological_process |
GO:0002634 | Regulation of germinal center formation | NAS | biological_process |
GO:0002829 | Negative regulation of type 2 immune response | IEA | biological_process |
GO:0002903 | Negative regulation of B cell apoptotic process | NAS | biological_process |
GO:0003682 | Chromatin binding | IDA | molecular_function |
GO:0003700 | Sequence-specific DNA binding transcription factor activity | IMP | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005634 | Nucleus | IDA IEA | cellular_component |
GO:0005657 | Replication fork | IDA | cellular_component |
GO:0005730 | Nucleolus | IDA | cellular_component |
GO:0006351 | Transcription, DNA-templated | IEA | biological_process |
GO:0006954 | Inflammatory response | IEA | biological_process |
GO:0006974 | Cellular response to DNA damage stimulus | IDA | biological_process |
GO:0007266 | Rho protein signal transduction | IEA | biological_process |
GO:0007283 | Spermatogenesis | IEA | biological_process |
GO:0008104 | Protein localization | IEA | biological_process |
GO:0008285 | Negative regulation of cell proliferation | IEA | biological_process |
GO:0030036 | Actin cytoskeleton organization | IEA | biological_process |
GO:0030183 | B cell differentiation | IEA | biological_process |
GO:0030308 | Negative regulation of cell growth | IDA | biological_process |
GO:0030890 | Positive regulation of B cell proliferation | IEA | biological_process |
GO:0031490 | Chromatin DNA binding | IEA | molecular_function |
GO:0032319 | Regulation of Rho GTPase activity | IEA | biological_process |
GO:0032764 | Negative regulation of mast cell cytokine production | IEA | biological_process |
GO:0035024 | Negative regulation of Rho protein signal transduction | IEA | biological_process |
GO:0042092 | Type 2 immune response | IEA | biological_process |
GO:0043065 | Positive regulation of apoptotic process | IDA | biological_process |
GO:0043066 | Negative regulation of apoptotic process | IEA | biological_process |
GO:0043380 | Regulation of memory T cell differentiation | IEA | biological_process |
GO:0043565 | Sequence-specific DNA binding | IDA IEA | molecular_function |
GO:0045629 | Negative regulation of T-helper 2 cell differentiation | IEA | biological_process |
GO:0045892 | Negative regulation of transcription, DNA-templated | IMP NAS | biological_process |
GO:0046872 | Metal ion binding | IEA | molecular_function |
GO:0048294 | Negative regulation of isotype switching to IgE isotypes | IEA | biological_process |
GO:0048821 | Erythrocyte development | IEA | biological_process |
GO:0050727 | Regulation of inflammatory response | IEA | biological_process |
GO:0050776 | Regulation of immune response | NAS | biological_process |
GO:0051272 | Positive regulation of cellular component movement | IEA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0850615250 | 0.4764290718 | 0.6135589814 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.2796146023 |
GSE13712_SHEAR | Up | 0.6823599289 |
GSE13712_STATIC | Up | 0.0367898840 |
GSE19018 | Down | -0.2550255652 |
GSE19899_A1 | Down | -0.1141614437 |
GSE19899_A2 | Up | 0.0129707973 |
PubMed_21979375_A1 | Up | 0.6088363257 |
PubMed_21979375_A2 | Up | 0.1074083441 |
GSE35957 | Down | -0.2043006480 |
GSE36640 | Up | 0.4361703994 |
GSE54402 | Up | 0.1259187317 |
GSE9593 | Down | -0.1412209280 |
GSE43922 | Down | -0.0594486682 |
GSE24585 | Up | 0.6409305506 |
GSE37065 | Up | 0.3292572353 |
GSE28863_A1 | Up | 0.3112776720 |
GSE28863_A2 | Up | 0.2799462254 |
GSE28863_A3 | Up | 0.3907151648 |
GSE28863_A4 | Down | -0.4292480102 |
GSE48662 | Down | -0.1757628682 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-9-5p | MIMAT0000441 | MIRT000640 | Luciferase reporter assay | Non-Functional MTI | 19956200 |
hsa-miR-127-3p | MIMAT0000446 | MIRT004463 | Luciferase reporter assay | Functional MTI | 17581274 |
hsa-miR-127-3p | MIMAT0000446 | MIRT004463 | Luciferase reporter assay//Microarray//Northern blot//qRT-PCR//Western blot | Functional MTI | 16766263 |
hsa-miR-339-5p | MIMAT0000764 | MIRT005929 | qRT-PCR | Functional MTI (Weak) | 20932331 |
hsa-miR-30b-5p | MIMAT0000420 | MIRT006324 | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 22387553 |
hsa-miR-155-5p | MIMAT0000646 | MIRT006927 | Luciferase reporter assay | Functional MTI | 23041630 |
hsa-miR-335-5p | MIMAT0000765 | MIRT017492 | Microarray | Functional MTI (Weak) | 18185580 |
hsa-miR-124-3p | MIMAT0000422 | MIRT022507 | Microarray | Functional MTI (Weak) | 18668037 |
hsa-miR-21-5p | MIMAT0000076 | MIRT035524 | Luciferase reporter assay | Functional MTI | 23416424 |
Entries Per Page
Displaying Page of
- mirRecord
MicroRNA name | mirBase ID | Target site number | MiRNA mature ID | Test method inter | MiRNA regulation site | Reporter target site | Pubmed ID |
---|---|---|---|---|---|---|---|
hsa-miR-127-3p | MIMAT0000446 | 1 | hsa-miR-127-3p | {Western blot}{Western blot} | {overexpression by 5-Aza-Deoxycytidine and phenylbutyrate treatment}{overexpression by miRNA precursor transfection} | 16766263 |
Entries Per Page
Displaying Page of
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 4 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
24282530 | In this report, we identified miR-127 as a novel regulator of cellular senescence that directly targets BCL6 |
24282530 | We further showed that miR-127 is down-regulated in breast cancer tissues and that this down-regulation is associated with up-regulation of BCL6 |
24282530 | Over-expression of miR-127 or depletion of BCL6 inhibits breast cancer cell proliferation |
24282530 | Our data suggest that miR-127 may function as a tumor suppressor that modulates the oncogene BCL6 |
23209284 | Bcl6, which functions as a transcriptional repressor, has been identified as a potent inhibitor of cell senescence, but a role of Bcl6 in the accumulation of somatic mutations has remained unclear |
23209284 | The ADAR1 (adenosine deaminase acting on RNA1) gene was overexpressed in Bcl6-deficient cells, and its promoter analysis revealed that ADAR1 is a molecular target of Bcl6 |
23209284 | Thus, Bcl6 protects senescent cells from accumulation of adenosine-targeted DNA mutations induced by ADAR1 |
23049957 | Inhibition of doxorubicin-induced senescence by PPARdelta activation agonists in cardiac muscle cells: cooperation between PPARdelta and Bcl6 |
23049957 | This occurs through its interference with the transcriptional repressor protein B cell lymphoma-6 (Bcl6) |
23049957 | Low doses of doxorubicin increase the expression of PPARdelta that sequesters Bcl6, thus preventing it from exerting its anti-senescent effects |
23049957 | We also found that L-165041, a specific PPARdelta activator, is highly effective in protecting cardiomyocytes from doxorubicin-induced senescence through a Bcl6 related mechanism |
23049957 | However, while experiments performed with siRNA analysis techniques very clearly showed the weight of Bcl6 in the cellular senescence program, no role was found for Bcl6 in the anti-apoptotic effects of L-165041, thus confirming that senescence and apoptosis are two very distinct stress response cellular programs |
17981205 | Superimposed on this basic scheme are a shift in the CD8(+) T cell response to type I and II interferon (IFN) from anti- to pro-proliferative and transcriptional control of replicative senescence by Bmi-1, Blimp-1, and BCL6/BCL6b |
Entries Per Page
Displaying Page of